Operating
Net Income
Vertex Pharmaceuticals Net Income increased by 10.0% to $1.19B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 19.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase signals improved profitability and potential for higher dividends or reinvestment, while a decrease may indicate rising costs or slowing sales.
Detailed definition
Net income represents the total profit of the company after all operating expenses, interest, taxes, and preferred stock...
Peer comparison
Peer companies in the consumer electronics and software sectors typically trade on multiples of this figure, though it can be impacted by one-time tax events.
Metric ID:
cf_net_incomeHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66.92M | $851.93M | $770.11M | $762.10M | $810.50M | $930.50M | $818.90M | $699.80M | $915.70M | $1.04B | $968.80M | $1.10B | -$3.59B | $1.05B | $646.30M | $1.03B | $1.08B | $1.19B |
| QoQ Change | — | >999% | -9.6% | -1.0% | +6.4% | +14.8% | -12.0% | -14.5% | +30.9% | +13.1% | -6.4% | +13.5% | -426.8% | +129.1% | -38.2% | +59.8% | +4.8% | +10.0% |
| YoY Change | — | — | — | — | >999% | +9.2% | +6.3% | -8.2% | +13.0% | +11.3% | +18.3% | +57.1% | -492.4% | +1.0% | -41.2% | +128.7% | +3.6% | — |
Range-$3.59B – $1.19B
CAGR+96.9%
Avg YoY Growth+62.9%
Median YoY Growth+9.2%
Current Streak3 quarters growth
Business Segments
Loading segment data...
Net Income at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's net income?
- Vertex Pharmaceuticals (VRTX) reported net income of $1.19B in Q4 2025.
- What is the long-term trend for Vertex Pharmaceuticals's net income?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's net income has grown at a 19.1% compound annual growth rate (CAGR), from $2.34B to $3.95B.
- What does net income mean?
- The company's total profit after all expenses and taxes have been paid.